Callan Jmb Inc. (CJMB) · Oct 16, 2026 · Delisting
Nasdaq delisting appeal — $2.5M equity requirement unmet; suspension stayed pending Panel decision
Callan JMB’s Nasdaq delisting risk intensifies after it misses the equity deadline. Its appeal pauses suspension, but the capital shortfall remains unresolved.
Callan JMB is a small cold-chain logistics and fulfillment company serving life-sciences, healthcare, and emergency-response customers; its growth plan depends on continued access to capital. The financing plan did not solve the immediate listing problem. Nasdaq required at least $2.5 million of stockholders’ equity, but Callan JMB failed to complete its capital-raising initiatives or otherwise demonstrate compliance by the October 5, 2026 extension deadline. The Staff therefore determined that the company had not met the extension terms (Item 3.01) 〔0〕
The appeal is procedural relief, not a business fix. Callan JMB requested a Nasdaq hearing on October 14, and that request temporarily prevents suspension and the filing of Form 25-NSE while the Panel considers the case (Item 3.01) 〔1〕 This keeps the listing alive for now, but the filing provides no completed financing, equity injection, or other evidence that the underlying shortfall has been cured.
The downside is therefore asymmetric. The company has bought time to argue for continued listing, but it still needs to prove compliance and acknowledges there is no assurance the Panel will grant relief or that it can maintain Nasdaq compliance (Item 3.01) 〔2〕
Bottom line: This moves the story from a warning to an active delisting appeal. The hearing delays the immediate consequence, but the failed capital raise leaves Callan JMB’s Nasdaq status and financing flexibility materially unresolved.
Nasdaq Hearings Panel decision
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!